Cysteine Hydrochloride is used for treating patients needing parenteral nutrition through intravenous administration of a diluted cysteine hydrochloride solution. It was first introduced by Hospira Inc in its drug Cysteine Hydrochloride on Oct 22, 1986. Other drugs containing Cysteine Hydrochloride are Elcys, Nouress. 5 different companies have introduced drugs containing Cysteine Hydrochloride.

Cysteine Hydrochloride Patents

Given below is the list of patents protecting Cysteine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Nouress	US10493051	Cysteine composition and injection	Mar 15, 2039	Baxter Hlthcare Corp
Nouress	US10543186	Cysteine composition and injection	Mar 15, 2039	Baxter Hlthcare Corp
Nouress	US10702490	Cysteine composition and injection	Mar 15, 2039	Baxter Hlthcare Corp
Nouress	US11045438	Cysteine composition and injection	Mar 15, 2039	Baxter Hlthcare Corp
Nouress	US11510941	Stable, highly pure L-cysteine compositions for injection and methods of use	Mar 02, 2039	Baxter Hlthcare Corp
Elcys	US10478453	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US10583155	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US10653719	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US10905713	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US10905714	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US10912795	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US10918662	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US10933089	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US11510941	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US11510942	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US11642370	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US11648262	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US11679125	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US11684636	Stable, highly pure l-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US11826383	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Elcys	US11969439	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Exela Pharma
Nouress	US10478453	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US10583155	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US10653719	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US10905713	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US10905714	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US10912795	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US10918662	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US10933089	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US11510942	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US11642370	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US11648262	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US11679125	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US11684636	Stable, highly pure l-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp
Nouress	US11826383	Stable, highly pure L-cysteine compositions for injection and methods of use	Jan 15, 2039	Baxter Hlthcare Corp

Add above patents to watchlist

Cysteine Hydrochloride's Family Patents

Full family tree

Cysteine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Cysteine Hydrochloride. The first generic version for Cysteine Hydrochloride was by Dr Reddys Laboratories Sa and was approved on Apr 8, 2022. And the latest generic version is by Hikma Pharmaceuticals Usa Inc and was approved on Jan 26, 2023.

Given below is the list of companies who have filed for Cysteine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.